Standard

2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. / Puis, Luc; Milojevic, Milan; Boer, Christa et al.

In: Interactive cardiovascular and thoracic surgery, Vol. 30, No. 2, 01.02.2020, p. 161-202.

Research output: Contribution to journalArticlepeer-review

Harvard

Puis, L, Milojevic, M, Boer, C, De Somer, FMJJ, Gudbjartsson, T, Van Den Goor, J, Jones, TJ, Lomivorotov, V, Merkle, F, Ranucci, M, Kunst, G, Wahba, A, Alston, P, Fitzgerald, D, Nikolic, A, Onorati, F, Steen Rasmussen, B & Svenmarker, S 2020, '2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery', Interactive cardiovascular and thoracic surgery, vol. 30, no. 2, pp. 161-202. https://doi.org/10.1093/icvts/ivz251

APA

Puis, L., Milojevic, M., Boer, C., De Somer, F. M. J. J., Gudbjartsson, T., Van Den Goor, J., Jones, T. J., Lomivorotov, V., Merkle, F., Ranucci, M., Kunst, G., Wahba, A., Alston, P., Fitzgerald, D., Nikolic, A., Onorati, F., Steen Rasmussen, B., & Svenmarker, S. (2020). 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Interactive cardiovascular and thoracic surgery, 30(2), 161-202. https://doi.org/10.1093/icvts/ivz251

Vancouver

Puis L, Milojevic M, Boer C, De Somer FMJJ, Gudbjartsson T, Van Den Goor J et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Interactive cardiovascular and thoracic surgery. 2020 Feb 1;30(2):161-202. doi: 10.1093/icvts/ivz251

Author

Puis, Luc ; Milojevic, Milan ; Boer, Christa et al. / 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. In: Interactive cardiovascular and thoracic surgery. 2020 ; Vol. 30, No. 2. pp. 161-202.

BibTeX

@article{218967808b534b2f8bd2f43098d7f80c,
title = "2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery",
abstract = "Disclaimer 2019: The EACTS/EACTA/EBCP Guidelines represent the views of the EACTS, the EACTA and EBCP and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating. The EACTS, EACTA and EBCP are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the EACTS, EACTA and EBCP Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EACTS, EACTA and EBCP Guidelines fully into account when exercising their clinical judgement as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the EACTS, EACTA and EBCP Guidelines do not, in any way whatsoever, override the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient{\textquoteright}s health condition and, where appropriate and/or necessary, in consultation with that patient and the patient{\textquoteright}s care provider. Nor do the EACTS, EACTA and EBCP Guidelines exempt health professionals from giving full and careful consideration to the relevant official, updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient{\textquoteright}s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional{\textquoteright}s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription. The article has been co-published with permission in the British Journal of Anaesthesia, the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery.",
author = "Luc Puis and Milan Milojevic and Christa Boer and {De Somer}, {Filip M.J.J.} and Tomas Gudbjartsson and {Van Den Goor}, Jenny and Jones, {Timothy J.} and Vladimir Lomivorotov and Frank Merkle and Marco Ranucci and Gudrun Kunst and Alexander Wahba and Peter Alston and David Fitzgerald and Aleksandar Nikolic and Francesco Onorati and {Steen Rasmussen}, Bodil and Staffan Svenmarker",
note = "Funding Information: Conflict of interest: Filip M.J.J. De Somer: Speaker and consultancy fees paid to the University of Ghent. Speaker fee from Fresenius Kabi and Maquet Cardiopulmonary. Vladimir Lomivorotov: Speaking honoraria from Baxter, AbbVie and Orion Pharma. Frank Merkle: Speaker Bureau/Hospital contract for LivaNova. Marco Ranucci: Consultancy fees from LivaNova and Medtronic and royalties from LivaNova for the commercial application of a patent on a metabolic monitoring system; research grant from Roche Diagnostics; personal fees from Haemonetics, IL-Werfen Grifols and Vigor. All other authors declared no conflict of interest. Publisher Copyright: {\textcopyright} 2020 Oxford University Press. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = feb,
day = "1",
doi = "10.1093/icvts/ivz251",
language = "English",
volume = "30",
pages = "161--202",
journal = "Interactive cardiovascular and thoracic surgery",
issn = "1569-9293",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery

AU - Puis, Luc

AU - Milojevic, Milan

AU - Boer, Christa

AU - De Somer, Filip M.J.J.

AU - Gudbjartsson, Tomas

AU - Van Den Goor, Jenny

AU - Jones, Timothy J.

AU - Lomivorotov, Vladimir

AU - Merkle, Frank

AU - Ranucci, Marco

AU - Kunst, Gudrun

AU - Wahba, Alexander

AU - Alston, Peter

AU - Fitzgerald, David

AU - Nikolic, Aleksandar

AU - Onorati, Francesco

AU - Steen Rasmussen, Bodil

AU - Svenmarker, Staffan

N1 - Funding Information: Conflict of interest: Filip M.J.J. De Somer: Speaker and consultancy fees paid to the University of Ghent. Speaker fee from Fresenius Kabi and Maquet Cardiopulmonary. Vladimir Lomivorotov: Speaking honoraria from Baxter, AbbVie and Orion Pharma. Frank Merkle: Speaker Bureau/Hospital contract for LivaNova. Marco Ranucci: Consultancy fees from LivaNova and Medtronic and royalties from LivaNova for the commercial application of a patent on a metabolic monitoring system; research grant from Roche Diagnostics; personal fees from Haemonetics, IL-Werfen Grifols and Vigor. All other authors declared no conflict of interest. Publisher Copyright: © 2020 Oxford University Press. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - Disclaimer 2019: The EACTS/EACTA/EBCP Guidelines represent the views of the EACTS, the EACTA and EBCP and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating. The EACTS, EACTA and EBCP are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the EACTS, EACTA and EBCP Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EACTS, EACTA and EBCP Guidelines fully into account when exercising their clinical judgement as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the EACTS, EACTA and EBCP Guidelines do not, in any way whatsoever, override the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and, where appropriate and/or necessary, in consultation with that patient and the patient’s care provider. Nor do the EACTS, EACTA and EBCP Guidelines exempt health professionals from giving full and careful consideration to the relevant official, updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription. The article has been co-published with permission in the British Journal of Anaesthesia, the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery.

AB - Disclaimer 2019: The EACTS/EACTA/EBCP Guidelines represent the views of the EACTS, the EACTA and EBCP and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating. The EACTS, EACTA and EBCP are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the EACTS, EACTA and EBCP Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EACTS, EACTA and EBCP Guidelines fully into account when exercising their clinical judgement as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the EACTS, EACTA and EBCP Guidelines do not, in any way whatsoever, override the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and, where appropriate and/or necessary, in consultation with that patient and the patient’s care provider. Nor do the EACTS, EACTA and EBCP Guidelines exempt health professionals from giving full and careful consideration to the relevant official, updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription. The article has been co-published with permission in the British Journal of Anaesthesia, the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery.

UR - http://www.scopus.com/inward/record.url?scp=85079023406&partnerID=8YFLogxK

U2 - 10.1093/icvts/ivz251

DO - 10.1093/icvts/ivz251

M3 - Article

C2 - 31576402

AN - SCOPUS:85079023406

VL - 30

SP - 161

EP - 202

JO - Interactive cardiovascular and thoracic surgery

JF - Interactive cardiovascular and thoracic surgery

SN - 1569-9293

IS - 2

ER -

ID: 26069981